BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 23703577)

  • 1. Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.
    Ude C; Schubert-Zsilavecz M; Wurglics M
    Clin Pharmacokinet; 2013 Sep; 52(9):727-49. PubMed ID: 23703577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VERIFICATION OF AUTHENTICITY OF
    Budeč M; Bošnir J; Racz A; Lasić D; Brkić D; Mosović Ćuić A; Kuharić Ž; Jurak G; Barušić L
    Acta Clin Croat; 2019 Dec; 58(4):672-692. PubMed ID: 32595253
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicinal Values and Potential Risks Evaluation of
    Su X; Shi R; Hu H; Hu L; Wei Q; Guan Y; Chang J; Li C
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals.
    van Beek TA; Montoro P
    J Chromatogr A; 2009 Mar; 1216(11):2002-32. PubMed ID: 19195661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixing Ginkgo biloba Extract with Sesame Extract and Turmeric Oil Increases Bioavailability of Ginkgolide A in Mice Brain.
    Iwamoto K; Kawamoto H; Takeshita F; Matsumura S; Ayaki I; Moriyama T; Zaima N
    J Oleo Sci; 2019 Sep; 68(9):923-930. PubMed ID: 31413248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative vasodilating actions among terpenoids and flavonoids contained in Ginkgo biloba extract.
    Nishida S; Satoh H
    Clin Chim Acta; 2004 Jan; 339(1-2):129-33. PubMed ID: 14687903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemistry and biology of terpene trilactones from Ginkgo biloba.
    Strømgaard K; Nakanishi K
    Angew Chem Int Ed Engl; 2004 Mar; 43(13):1640-58. PubMed ID: 15038029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic exposure to Ginkgo biloba extract in male F344/NCrl rats: Relevance to humans.
    Waidyanatha S; Mutlu E; Gibbs S; Stiffler B; Andre J; Burback B; Rider CV
    Food Chem Toxicol; 2019 Sep; 131():110586. PubMed ID: 31202939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and brain levels of terpene trilactones in rats after an oral single dose of standardized Ginkgo biloba extract EGb 761®.
    Ude C; Paulke A; Nöldner M; Schubert-Zsilavecz M; Wurglics M
    Planta Med; 2011 Feb; 77(3):259-64. PubMed ID: 20814851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential of
    Biernacka P; Adamska I; Felisiak K
    Molecules; 2023 May; 28(10):. PubMed ID: 37241734
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats.
    Chen ZP; Sun J; Chen HX; Xiao YY; Liu D; Chen J; Cai H; Cai BC
    Fitoterapia; 2010 Dec; 81(8):1045-52. PubMed ID: 20603197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advance in study of ginkgolic acid contained in Ginkgo biloba preparations].
    Liu P; Pan S
    Zhongguo Zhong Yao Za Zhi; 2012 Feb; 37(3):274-7. PubMed ID: 22568222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults.
    Mix JA; Crews WD
    J Altern Complement Med; 2000 Jun; 6(3):219-29. PubMed ID: 10890330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration.
    Chen F; Li L; Xu F; Sun Y; Du F; Ma X; Zhong C; Li X; Wang F; Zhang N; Li C
    Br J Pharmacol; 2013 Sep; 170(2):440-57. PubMed ID: 23808355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
    Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT
    J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical quality of different Ginkgo biloba brands.
    Kressmann S; Müller WE; Blume HH
    J Pharm Pharmacol; 2002 May; 54(5):661-9. PubMed ID: 12005361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for toxic effects of alkylphenols from Ginkgo biloba in the hen's egg test (HET).
    Baron-Ruppert G; Luepke NP
    Phytomedicine; 2001 Mar; 8(2):133-8. PubMed ID: 11315756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ginkgo biloba extract (EGb 761). State of knowledge in the dawn of the year 2000].
    Clostre F
    Ann Pharm Fr; 1999 Jul; 57 Suppl 1():1S8-88. PubMed ID: 10481350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats.
    Guan H; Qian D; Ren H; Zhang W; Nie H; Shang E; Duan J
    J Ethnopharmacol; 2014 Aug; 155(1):758-68. PubMed ID: 24953034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of the flavonoid glycosides and terpene trilactones in the extract of Ginkgo biloba and evaluation of their inhibitory activity towards fibril formation of β-amyloid peptide.
    Xie H; Wang JR; Yau LF; Liu Y; Liu L; Han QB; Zhao Z; Jiang ZH
    Molecules; 2014 Apr; 19(4):4466-78. PubMed ID: 24727418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.